Indian patent office grants acurx patent for dna polymerase iiic inhibitors

Staten island, n.y. , april 17, 2025 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that a new patent has been granted by the indian patent office in march 2025.
DNA Ratings Summary
DNA Quant Ranking